Puma Biotechnology Inc Asset Resilience Ratio

Latest as of December 2025: 31.39%

Puma Biotechnology Inc asset resilience ratio. Puma Biotechnology Inc (PBYI) has an Asset Resilience Ratio of 31.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Puma Biotechnology Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$67.90 Million

Cash + Short-term Investments

Total Assets

$216.30 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Puma Biotechnology Inc (2011–2025)

Asset resilience ratio of Puma Biotechnology Inc from 2011 to 2025. This chart shows how Puma Biotechnology Inc's Asset Resilience Ratio has changed over time. Read PBYI liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Puma Biotechnology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Puma Biotechnology Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$67.90 Million	31.39%
Total Liquid Assets	$67.90 Million	31.39%

Asset Resilience Insights

Very High Liquidity: Puma Biotechnology Inc maintains exceptional liquid asset reserves at 31.39% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Puma Biotechnology Inc Industry Peers by Asset Resilience Ratio

Compare Puma Biotechnology Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Puma Biotechnology Inc Asset Resilience Ratio by Year (2011–2025)

Puma Biotechnology Inc asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Puma Biotechnology Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	31.39%	$67.89 Million	$216.30 Million	+16.51pp
2024-12-31	14.88%	$31.75 Million	$213.33 Million	+9.96pp
2023-12-31	4.93%	$11.35 Million	$230.53 Million	+2.73pp
2022-12-31	2.19%	$4.87 Million	$222.06 Million	-6.18pp
2021-12-31	8.37%	$18.98 Million	$226.59 Million	+5.06pp
2020-12-31	3.32%	$8.10 Million	$244.22 Million	-18.65pp
2019-12-31	21.97%	$51.61 Million	$234.91 Million	-0.03pp
2018-12-31	22.00%	$57.00 Million	$259.12 Million	--
2017-12-31	0.00%	$0.00	$165.53 Million	--
2016-12-31	13.85%	$35.00 Million	$252.79 Million	-63.00pp
2015-12-31	76.84%	$184.30 Million	$239.84 Million	+13.68pp
2014-12-31	63.16%	$102.80 Million	$162.76 Million	+23.97pp
2013-12-31	39.19%	$40.90 Million	$104.37 Million	--
2012-12-31	0.00%	$0.00	$151.70 Million	--
2011-12-31	0.00%	$0.00	$55.40 Million	--

pp = percentage points

About Puma Biotechnology Inc

NASDAQ:PBYI USA Biotechnology

Market Cap

$419.73 Million

Market Cap Rank

#13295 Global

#3250 in USA

Share Price

$8.25

Change (1 day)

-15.56%

52-Week Range

$4.73 - $11.26

All Time High

$132.45